As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 6, 2015
by Alzheimer’s Society:
Insulin delivered high up in the nasal cavity goes to affected areas of the brain with lasting results in improving memory, according to researchers at the UW Medicine, Veteran’s Administration Puget Sound and Saint Louis University.
The study, published online (30 July 2015) in the Journal of Alzheimer’s Disease, looked at mice aged 8-12 months who did not remember whether objects they were presented to play with were new or old. Researchers said after a single dose of intranasal insulin they could remember which objects they had seen before.
Dr Ian Le Guillou, Alzheimer’s Society’s Research Officer said:
‘We know that insulin is important to ensure the healthy functioning of brain cells, but this process is disrupted in people with Alzheimer’s disease. Providing insulin through the nose is a promising potential treatment but there is still a lot we don’t know about how it acts in the body. This study looked at how nasally-delivered insulin behaves in mice, but it remains to be seen if this will also apply to humans.
‘As we have learnt more about the importance of insulin resistance in Alzheimer’s disease, it has become a popular area of research. Alzheimer’s Society is currently part-funding a trial into the diabetes drug liraglutide for people with mild Alzheimer’s disease, which we hope will result in a new treatment for the condition.’
Join us for conversation and reception with 8-time Juno Award winning Singer-Songwriter & Actress Jann Arden, along with Your Morning Host Anne-Marie Mediwake. Whether she is captivating audiences with her heartfelt music, entertaining them with...
Chronic pain can impact everything from your mood, to your sleep to your social life. “The first things we lose are fun activities and leisure and we end up only doing what we...
A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease....
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.
